Impact of a Series of Interventions in Vancomycin Prescribing on Use and Prevalence of Vancomycin-Resistant Enterococci

被引:11
作者
Guglielmo, B. Joseph [1 ]
Dudas, Vicky [2 ]
Maewal, Ila [2 ]
Young, Rebecca [2 ]
Hilts, Alexandra [3 ]
Villmann, Mark [4 ]
Gibbs, Laurel [5 ]
Gropper, Michael [6 ]
Jacobs, Richard [7 ]
机构
[1] Univ Calif San Francisco, Dept Clin Pharm, Clin Pharm, San Francisco, CA 94143 USA
[2] UCSF, Sch Pharm, San Francisco, CA USA
[3] Univ Colorado Hosp, Dept Pharmaceut Serv, Denver, CO USA
[4] Jackson Mem Hosp, Pharm Serv, Miami, FL 33136 USA
[5] UCSF, Med Ctr, Dept Hosp Epidemiol & Infect Control, San Francisco, CA USA
[6] UCSF, Dept Anesthesia, San Francisco, CA USA
[7] UCSF, Dept Med, Sch Med, Div Infect Dis,Med, San Francisco, CA USA
关键词
D O I
10.1016/S1553-7250(05)31061-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: In response to vancomycin-resistant bacteria, particularly vancomycin-resistant enterococci (VRE), measures have been recommended to improve on the appropriate use of vancomycin. Methods: Intervention 1 consisted of an automatic 72-hour vancomycin stop order; Intervention 2, a standardized procedure for sampling of blood cultures; and Intervention 3, an interdisciplinary critical care team. Results: After Intervention 1, inappropriate use decreased, particularly in treatment of febrile neutropenia and undocumented gram-positive infections. After Intervention 2, the baseline rate of inappropriately drawn blood cultures (IDBCs) was unchanged, and use in patients with IDBCs was comparable during both periods. Before Intervention 3, 38/55 orders continuing > 72 hours were considered inappropriate versus 24/53 (p < .025) after. After the interventions, hospitalwide vancomycin use was reduced. Yet the overall rate of VRE infection initially decreased but then increased once again over time. Discussion: Despite substantial reduction in hospitalwide vancomycin use, the impact on the overall rate of VRE was inconsistent and ward dependent.
引用
收藏
页码:469 / 475
页数:7
相关论文
共 18 条
[1]   Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium [J].
Anglim, AM ;
Klym, B ;
Byers, KE ;
Scheld, WM ;
Farr, BM .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (10) :1132-1136
[2]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[3]   Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients [J].
Bhalla, A ;
Pultz, NJ ;
Ray, AJ ;
Hoyen, CK ;
Eckstein, EC ;
Donskey, CJ .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (09) :644-649
[4]   Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant enterococcus [J].
Carmeli, Y ;
Eliopoulos, GM ;
Samore, MH .
EMERGING INFECTIOUS DISEASES, 2002, 8 (08) :802-807
[5]   Antimicrobial resistance trends and outbreak frequency in United States hospitals [J].
Diekema, DJ ;
BootsMiller, BJ ;
Vaughn, TE ;
Woolson, RF ;
Yankey, JW ;
Ernst, EJ ;
Flach, SD ;
Ward, MM ;
Franciscus, CLJ ;
Pfaller, MA ;
Doebbeling, BN .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (01) :78-85
[6]   Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. [J].
Donskey, CJ ;
Chowdhry, TK ;
Hecker, MT ;
Hoyen, CK ;
Hanrahan, JA ;
Hujer, AM ;
Hutton-Thomas, RA ;
Whalen, CC ;
Bonomo, RA ;
Rice, LB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1925-1932
[7]   Vancomycin use in a university medical center: Effect of a vancomycin continuation form [J].
Evans, ME ;
Millheim, ET ;
Rapp, RP .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (06) :417-420
[8]   An interventional program to improve antibiotic use [J].
Feucht, CL ;
Rice, LB .
ANNALS OF PHARMACOTHERAPY, 2003, 37 (05) :646-651
[9]   The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units [J].
Fridkin, SK ;
Edwards, JR ;
Courval, JM ;
Hill, H ;
Tenover, FC ;
Lawton, R ;
Gaynes, RP ;
McGowan, JE .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (03) :175-183
[10]  
Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1